Results 151 to 160 of about 21,216 (279)

Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling

open access: yesClinical Pharmacokinetics, 2020
Xiaomei I. Liu   +9 more
semanticscholar   +1 more source

Effects of switching from efavirenz to raltegravir on endothelial function, bone mineral metabolism, inflammation, and renal function: a randomized, controlled trial [PDF]

open access: yes, 2013
We performed a randomized controlled trial in 30 HIV-infected participants to either continue tenofovir/emtricitabine/efavirenz (Continuation Group) or switch to tenofovir/emtricitabine/raltegravir (Switch Group) for 24 weeks.
Dubé, Michael P.   +4 more
core  

The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection

open access: yesТерапевтический архив, 2014
AIM. To evaluate the efficiency and safety of using raltegravir (RAL) twice daily in conjunction with a once-daily fixed dose combination of abacavir (ABC)/lamivudine (3TC) in patients with HIV infection and active tuberculosis who have not previously ...
A V Kravchenko   +7 more
doaj  

Time taken to reach undetectable viral loads in therapy-naïve HIV patients commencing ART [PDF]

open access: yes, 2015
Peer reviewedPublisher ...
Baguley, Steve   +5 more
core  

Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir [PDF]

open access: bronze, 2016
Florin Tuluc   +8 more
openalex   +1 more source

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.

open access: yesThe Lancet HIV, 2020
E. Joao   +27 more
semanticscholar   +1 more source

Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial [PDF]

open access: gold, 2022
Nolwenn Hall   +56 more
openalex   +1 more source

Home - About - Disclaimer - Privacy